EGFR L858R/T790M/C797S inhibitor (inno.N/Seoul National University Hospital/Seoul National University College of Medicine)

N/A

Report date: 2026/05/09 20:00:18
NME

Base Information

Drug NameEGFR L858R/T790M/C797S inhibitor (inno.N/Seoul National University Hospital/Seoul National University College of Medicine)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpidermal growth factor receptor erbB1 inhibitorsEGFR L858R inhibitorsEGFR T790M inhibitors +[4] 
TargetsEpidermal growth factor receptor erbB1EGFR L858REGFR T790M +[4] 
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSeoul National University Hospital
China Registration ClassN/A

Develop Information

Active CompaniesSeoul National University College Of MedicineHK Inno N CorpSeoul National University Hospital
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A